MLICM
IRMD icon

Metropolitan Life Insurance Company (MetLife)’s iRadimed IRMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-465
Closed -$20.5K – 1058
2024
Q1 		$20.5K Hold
465
– – ﹤0.01% 1856
2023
Q4 		$22.1K Hold
465
– – ﹤0.01% 1878
2023
Q3 		$20.6K Hold
465
– – ﹤0.01% 1885
2023
Q2 		$22.2K Hold
465
– – ﹤0.01% 1875
2023
Q1 		$18.3K Hold
465
– – ﹤0.01% 1926
2022
Q4 		$13.2K Hold
465
– – ﹤0.01% 2188
2022
Q3 		$14K Hold
465
– – ﹤0.01% 2183
2022
Q2 		$15.8K Hold
465
– – ﹤0.01% 2152
2022
Q1 		$20.9K Sell
465
-1,395
-75% -$64.5K ﹤0.01% 2074
2021
Q4 		$86K Buy
+1,860
New +$75K ﹤0.01% 2556

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IRMD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of iRadimed (IRMD) in Q2 2024, closing a stake of 465 shares — an estimated $20.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IRMD in Q4 2021 and held it in 10 quarters. The position peaked at $86K in Q4 2021. 139 funds tracked by Wall St. Rank hold IRMD as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining iRadimed position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 465 iRadimed shares in Q2 2024, an estimated $20.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in iRadimed in Q4 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s iRadimed position peaked at $86K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held iRadimed as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.